Found 1,117 investors
Kielo Growth

Kielo Growth

Finland

Kielo Growth is an incubator that is based in Oulu, Finland. The firm also focuses on seed-stage investments and invests companies operating in the hardware, B2B, B2C, cybersecurity, IoT, information technology and financial services sectors.
Accelerator Incubator

Kielvest Capital

United States

Kielvest Capital was a private company that invested in early-stage technology companies with a focus on laboratory and process instrument companies. Kielvest Capital was invested in companies in the fields of protein processing, biotechnology, web marketing, clinical field trial administration, residential construction, tankless water heaters, carpet recycling and medical prescription administration.
Venture Capital

Kingospring

South Korea

Kingospring is a venture capital firm based in Seongnam-si, South Korea. The firm seeks to invest in the internet of things, robot and artificial intelligence, biotech, and healthcare, big data, augmented reality/virtual reality, chipset, and materials sectors.
Venture Capital

K& Investment Partners

South Korea

Founded in 2015, K& Investment Partners is a venture capital firm based in Seoul, Korea. The firm seeks to invest in the Mobile, Big Data, IoT related HW, SW, Service, Web and Mobile based Games and Contents Services, New Technology-based Financial Services, Bio/Medical Devices, consumer Goods/Beauty.
Venture Capital
Kite Pharma

Kite Pharma

Los Angeles, California, United States

Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications..
Biotechnology Health Care Medical Venture Capital
KIZOO Technology Capital

KIZOO Technology Capital

Karlsruhe, Baden-Wurttemberg, Germany

KIZOO provides mentoring, seed and early-stage financing with a focus on rejuvenation biotech.
Finance Financial Services Marketing Venture Capital Venture Capital

KLP Enterprises

North Haven, Connecticut, United States

KLP Enterprises is an entrepreneurial investor group that finances biotechnology, clean technology, and software companies.
Venture Capital

Kohan Ventures

United States

Mr. Lavigne served as Board Member at Puppet and BMC Software. Mr. Lavigne serves as a Director at DocuSign. He is managing director of Lavrite, LLC and former Executive Vice President and Chief Financial Officer of Genentech Inc., leads DocuSign's Audit and Finance Committee. He brings decades of corporate finance, accounting, growth strategy and IT management experience to DocuSign's board. In his twenty-three years at Genentech, he led the company's financial, corporate relations and information technology groups as revenues grew from $40 million in 1983 to $300 million in 1988 when he became CFO to more than $6.5 billion in 2005 when he was named 'Best CFO in Biotech' by Institutional Investor. Mr. Lavigne is a Chairman and Member of the Board of Directors of Accuray, Inc. (Chairman of the Board & Compensation Committee), Allergan, Inc. (Member of the Audit and Finance & Science and Technology Committees), BMC Software (Chairman of the Audit Committee & Member of the M&A Committee), Depomed, Inc. (Audit Committee member), NovoCure (Audit Committee Chairman) and SafeNet, Inc. (Audit Committee Chairman). Previously, he was a Director and Chairman of the Audit Committee of several other public companies including Arena Pharmaceuticals, Equinix, Kyphon and Genova. Mr. Lavigne is also part of the Pacific SW Audit Committee Network of Audit Committee Chairs and Deloitte's Life Sciences Advisory Board. Mr. Lavigne is the managing member of Spring Development Group, LLC, a strategic investor in companies with unique growth opportunities. Mr. Lavigne is a board member and former Chairman of the UCSF Benioff Children's Hospitals. Mr. Lavigne is also a member of the West Coast Audit Committee Network and the faculty of the GLG Institute. He also served as Chairman of the Children's Hospital & Research Center Foundation. He serves as Board Member at Zynga.
Individual/Angel
KohFounders

KohFounders

Los Angeles, California, United States

Founded in 2013, Koh Founders helps early-stage entrepreneurs in digital healthcare, local, mobile, IoT, and software and services.
Venture Capital Incubator

Konstantin Gerhard

Canada

Mr. Olivier Giner serves as Chief Executive Officer at Adracare. He is an Angel Investor. He has more than 20 years of experience in operations, venture capital, M&A, and financings. Prior to joining Adracare, Mr. Giner served as Vice President and Chief Operating Officer at iGan Partners. Prior to joining iGan Partners, he was a director in CIBC World Markets' investment banking group, focusing on the telecom, media, and technology sectors. He also worked as a corporate lawyer for Clifford Chance in the United Kingdom and Stikeman Elliott in Montreal. He graduated with a Bachelor of Law Degree from Laval University and holds an MBA from INSEAD.
Individual/Angel
Korify Capital AG

Korify Capital AG

Switzerland

Korify Capital is a venture capital investment firm based in Basel, Switzerland. The firm has a strong focus on the biotech sector in the United States, Europe and Israel, but also selectively invests in fintech and blockchain opportunities.
Venture Capital
KSI Ventures

KSI Ventures

Russian Federation

KSI Ventures is a seed venture company and accelerator based in Moscow, Russia. The firm seeks to invest in pharmaceutics, medical equipment, cellular and genomic technology, agricultural biotechnology, VR/AR and neurotechnology sectors.
Venture Capital

Kuba Tymula

United States

Mr. Glen Sato served as a Partner at Cooley. He is also an Angel Investor. He is a partner in the Life Sciences and Public Securities practice groups and a member of Cooley Godward Kronish's Business department. He rejoined the Firm in 2006 and is resident in the Palo Alto office. Mr. Sato's practice focuses on corporate transactions, SEC reporting and compliance, disclosure issues, intellectual property licensing and licensing strategy, general corporate counseling, insider trading compliance and working with Boards of Directors and audit committees on various risk and accounting related matters. Together with strong finance capabilities, Sato also has substantial experience in corporate partnering, international and domestic M&A and other heavily negotiated transactions. He has worked closely with underwriters on public and private company acquisitions and led initial public, follow-on and secondary and convertible note offerings. He has also led or been significantly involved in corporate partnering and licensing transactions involving pharmaceutical and biotechnology companies such as Abbott, Bayer, Biogen Idec, Bristol-Myers Squibb, Exelixis, Eli Lilly, Genentech, GlaxoSmithKline, MedImmune, PDL BioPharma, Progenics, Roche, Sankyo and Tanox. Prior to joining the Firm, Mr. Sato served in diverse legal, financial, operational and strategic planning positions where his responsibilities included finance, business development, IS, HR and Facilities. He most recently served as Protein Design Labs' (PDL) Senior Vice President and Chief Financial Officer. He joined PDL from Exelixis, where he served as SVP, Chief Financial Officer and General Counsel for approximately three years. Prior to his time at Exelixis, he served in various legal and strategic planning positions at PDL, including Vice President, Legal and General Counsel. In addition, Mr. Sato worked at NeXT Computer as Associate General Counsel. He was an attorney in Cooley Godward Kronish's Business Department in Palo Alto for two years. Mr. Sato started his career at Jones, Day in Washington, DC. Mr. Sato received his JD and MBA from UCLA in 1987, where he was an Associate Editor of the Law Review. He received a Bachelor's degree in Economics and the College of Social Studies in 1981 from Wesleyan University. Mr. Sato is a member of the State Bar of California and an inactive member of the Washington, DC Bar Association.
Individual/Angel

Kunitake Saso

Tokyo, Japan, Asia

Kunitake Saso - CEO and Founder @ BIOTOPE
Individual/Angel
Kurma Partners

Kurma Partners

Paris, Ile-de-France, France

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology.
Biotechnology Financial Services Health Care Health Diagnostics Life Science Venture Capital

LaCambre Sicav

Luxembourg

Founded in 2018, LaCambre Sicav is a private equity firm headquartered in Luxembourg City, Luxembourg with a regional office based in Rome, Italy. The firm's platform is dedicated to the distribution of alternative investment with a focus on the internet of things (IoT) sector.
Private Equity Firm

Laetitia Garriott de Cayeux

New York, New York, United States

Laetitia Garriott de Cayeux - Advisor @ Global Space Ventures
Investment Partner Individual/Angel

Latartech Holdings

Israel

Latartech Holdings was an Israeli venture capital firm. The firm focused on investing in companies operating in the communications, biotechnology, engineering materials, home products, hardware and technology sectors. It specialized in seed, start-up and growth capital financing.
Venture Capital
Laurel Venture Capital

Laurel Venture Capital

China

Laurel Ventures is a venture capital firm based in Hangzhou, China. The firm seeks to invest in early and mid-stage life science companies operating primarily in therapeutic assets, innovative pharmaceutical, cancer immunotherapy, gene therapy, new antibiotics and life science technologies sectors.
Venture Capital

Laurence Grafstein

United States

Dr. Robert Carlson is a Co-Founder of Bioeconomy Capital and serves as its Managing Director. He also serves as Board Member at Lumen Bioscience, RoosterBio, and Parse Biosciences. He is an entrepreneur, author, scientist. Namesake of "Carlson Curves" and originator of the first estimates of global biotech revenues. He is the author of the book Biology is Technology: The Promise, Peril, and New Business of Engineering Life, published in 2010 by Harvard University Press; it received the PROSE award for the Best Engineering and Technology Book of 2010 and was named to the Best Books of 2010 lists by writers at both The Economist and Foreign Policy. He earned a doctorate in Physics from Princeton University in 1997.
Individual/Angel
Showing 641 to 660 of 1,117 results